特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952851

エピジェネティクス医薬品・診断技術の世界市場 - 種類別 (エピジェネティクス医薬品 (DNMT阻害剤、HDAC阻害剤)、エピジェネティクス診断技術)・地域別:市場規模・シェア・将来展望・機会分析

Epigenetics Drugs & Diagnostic Technologies Market, By Type (Epigenetic Drugs (DNMT Inhibitors, HDAC Inhibitors ), Epigenetics Diagnostic Technologies ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 155 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
エピジェネティクス医薬品・診断技術の世界市場 - 種類別 (エピジェネティクス医薬品 (DNMT阻害剤、HDAC阻害剤)、エピジェネティクス診断技術)・地域別:市場規模・シェア・将来展望・機会分析
出版日: 2020年07月24日
発行: Coherent Market Insights
ページ情報: 英文 155 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のエピジェネティクス医薬品および診断技術の市場について分析し、製品/技術の概要や、市場の基本構造および促進・抑制要因、全体的な市場規模の見通し (金額ベース、過去3年間・今後8年間分)、種類別・地域別の詳細動向、主要企業のプロファイル・業績・戦略計画などを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

  • 分析概要
  • エグゼクティブサマリー
    • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場のダイナミクス・規制・動向の分析

  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 影響度の分析
    • 近年の主な動き
    • 製品の上市
    • PEST分析
    • 技術進歩
    • 規制シナリオ
    • 企業合併・買収 (M&A)
    • 新型コロナウイルス感染症 (COVID-19) の市場への影響

第4章 世界のエピジェネティクス医薬品・診断技術市場:種類別

  • イントロダクション
    • 市場シェア分析 (最新値・予測値)
    • 対前年成長率 (YoY) の分析 (実績値・予測値)
    • 部門別の動向
  • エピジェネティック医薬品
    • イントロダクション
    • 市場規模とその予測、対前年成長率 (YoY) (実績値・予測値)
    • DNMT (DNAメチル基転移酵素) 阻害剤
    • アザシチジン
    • デシタビン
    • HDAC (ヒストン脱アセチル化酵素) 阻害剤
    • ボリノスタット
    • ロミデプシン
  • エピジェネティクス診断技術
    • イントロダクション
    • 市場規模とその予測、対前年成長率 (YoY) (実績値・予測値)
    • DNAメチル化
    • ChIP (クロマチン免疫沈降法) 技術

第5章 世界のエピジェネティクス医薬品・診断技術市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第6章 競合情勢

  • 企業プロファイル
    • 4SC AG
    • Acetylon Pharmaceuticals, Inc.
    • Astex Pharmaceuticals Inc.
    • CellCentric Ltd.
    • Celleron Therapeutics Ltd.
    • Celgene Corporation
    • Chroma Therapeutics Ltd.
    • Epigentek Group Inc.
    • エーザイ
    • EnVivo Pharmaceuticals Inc.
    • Base Genomics
    • Oryzon Genomics, S.A.

第7章 付録

目次

Epigenetic is the study of chemical modifications of some specific genes of an organism. Epigenetic drugs are used to reverse the abnormal gene expression which leads to different types of disease such as cancer, heart disease, diabetes, and mental illnesses. Increasing prevalence of cancer, increasing research and development for new drug molecule along with increasing investment in biotechnology industry is expected to propel the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Global Epigenetic Drugs and Diagnostic Technologies market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Epigenetic Drugs and Diagnostic Technologies market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, 4SC AG, Acetylon Pharmaceuticals, Inc., Astex Pharmaceuticals Inc., CellCentric Ltd., Celleron Therapeutics Ltd., Celgene Corporation, Chroma Therapeutics Ltd., Epigentek Group Inc., Eisai Co. Ltd., EnVivo Pharmaceuticals Inc., Base Genomics, and Oryzon Genomics, S.A.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Epigenetic Drugs and Diagnostic Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Epigenetic Drugs and Diagnostic Technologies market

Detailed Segmentation:

  • Global Epigenetic Drugs and Diagnostic Technologies Market, By Type:
    • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
    • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
  • Global Epigenetic Drugs and Diagnostic Technologies Market, By Region:
    • North America
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Epigenetic Drugs
      • DNMT Inhibitors
      • Azacitidine
      • Decitabine
      • HDAC Inhibitors
      • Vorinostat
      • Romidepsin
      • Epigenetics Diagnostic Technologies
      • DNA Methylation
      • ChIP Technology
      • By Country
      • North Africa
      • Central Africa
      • South Africa
  • Company Profiles
    • 4SC AG *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Acetylon Pharmaceuticals, Inc.
    • Astex Pharmaceuticals Inc.
    • CellCentric Ltd.
    • Celleron Therapeutics Ltd.
    • Celgene Corporation
    • Chroma Therapeutics Ltd.
    • Epigentek Group Inc.
    • Eisai Co. Ltd.
    • EnVivo Pharmaceuticals Inc.
    • Base Genomics
    • Oryzon Genomics, S.A.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • Impact of COVID19 on market

4. Global Epigenetic Drugs and Diagnostic Technologies Market, By Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Epigenetic Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • DNMT Inhibitors
    • Azacitidine
    • Decitabine
    • HDAC Inhibitors
    • Vorinostat
    • Romidepsin
  • Epigenetics Diagnostic Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • DNA Methylation
    • ChIP Technology

5. Global Epigenetic Drugs and Diagnostic Technologies Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • 4SC AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Acetylon Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Astex Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CellCentric Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celleron Therapeutics Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celgene Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Chroma Therapeutics Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Epigentek Group Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eisai Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • EnVivo Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Base Genomics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Oryzon Genomics, S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.